Article info
PDFEditorial
Crocodile tiers
- Dr D Shaw, Faculty of Medicine & Centre for Applied Ethics and Legal Philosophy, University of Glasgow, 378 Sauchiehall Street, Glasgow G2 3JZ; d.shaw{at}dental.gla.ac.uk
Citation
Crocodile tiers
Publication history
- Received June 16, 2008
- Accepted June 23, 2008
- First published July 30, 2008.
Online issue publication
April 27, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2008 BMJ Publishing Group & Institute of Medical Ethics
Other content recommended for you
- International experience of paying for expensive medicines
- A sixth of hospitals in England have expanded private patient options this year, the BMJ finds
- Should NHS patients be allowed to contribute extra money to their care?
- Optimising the use of cetuximab in the continuum of care for patients with metastatic colorectal cancer
- Targeted treatments in colorectal cancer: state of the art and future perspectives
- Patients in England are given green light to buy drugs privately alongside NHS care
- Will the fudge on equity sustain the NHS into the next millennium?
- A Postmarketing Surveillance Study on Erbitux (Cetuximab) in Patients With Metastatic Colorectal Cancer Refractory to Irinotecan-Containing Treatment
- Clinical activity and tolerability of FOLFIRI and cetuximab in elderly patients with metastatic colorectal cancer in the CAPRI-GOIM first-line trial
- Induction of natural killer antibody-dependent cell cytotoxicity and of clinical activity of cetuximab plus avelumab in non-small cell lung cancer